Srikanth Nagalla, M.D., is chief of benign hematology at Herbert Wertheim Cancer Institute. Dr. Nagalla specializes in treating benign (non-cancerous) hematological conditions, including bleeding and clotting disorders, rare blood disorders, high and low platelets, high and low blood counts, bone marrow failure syndromes and myeloproliferative neoplasms. In addition to his extensive experience in benign hematology, Dr. Nagalla has a master’s... Read More about Srikanth Nagalla, MD

Srikanth Nagalla, M.D., is chief of benign hematology at Herbert Wertheim Cancer Institute. Dr. Nagalla specializes in treating benign (non-cancerous) hematological conditions, including bleeding and clotting disorders, rare blood disorders, high and low platelets, high and low blood counts, bone marrow failure syndromes and myeloproliferative neoplasms. In addition to his extensive experience in benign hematology, Dr. Nagalla has a master’s... Read More about Srikanth Nagalla, MD